Thr300
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr300  -  ANKRD47 (human)

Site Information
sLDGtPQtREVAAEA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 38486816
Available spectra:  2 CST

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 )
Disease tissue studied:
lung cancer ( 1 , 2 , 3 , 4 ) , non-small cell lung cancer ( 1 , 2 , 4 ) , non-small cell lung adenocarcinoma ( 1 , 2 , 3 , 4 ) , non-small cell large cell lung carcinoma ( 1 ) , non-small cell squamous cell lung carcinoma ( 3 )
Relevant cell line - cell type - tissue:
Cal-12T (pulmonary) ( 4 ) , Calu-3 (pulmonary) ( 2 ) , HCC15 (pulmonary) ( 3 ) , HCC44 (pulmonary) ( 4 ) , HCC827 (pulmonary) ( 2 ) , LOU-NH91 (squamous) ( 3 ) , lung ( 1 , 2 , 3 , 4 ) , NCI-H1299 (pulmonary) ( 1 ) , NCI-H1437 (pulmonary) ( 4 ) , NCI-H1650 (pulmonary) ( 2 ) , NCI-H1666 (pulmonary) ( 4 ) , NCI-H1703 (squamous) ( 3 ) , NCI-H1734 (pulmonary) ( 1 ) , NCI-H1944 (pulmonary) ( 1 ) , NCI-H1975 (pulmonary) ( 2 ) , NCI-H2073 (pulmonary) ( 3 ) , NCI-H2106 (pulmonary) ( 2 ) , NCI-H2342 (pulmonary) ( 3 ) , NCI-H2405 (pulmonary) ( 4 ) , NCI-H358 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 1 )

References 

1

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

2

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

3

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

4

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info